Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001219036-21-000020

Chief Scientific Officer sold 100,000 shares at an average $34.68 ($3,467,764)

  • Chief Scientific Officer acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LANCHBURY JERRY S · Chief Scientific Officer

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-03 Exercise or conversion : show line 1 in the form +16,225 $26.49 $429,800 248,775 D
2021-08-03 Sale : show line 2 in the form −16,225 $33.99 $551,488 232,550 D
2021-08-03 Exercise or conversion : show line 3 in the form +1,775 $27.07 $48,049 234,325 D
2021-08-03 Sale : show line 4 in the form −1,775 $35.07 $62,249 232,550 D
2021-08-03 Exercise or conversion : show line 5 in the form +27,830 $23.98 $667,363 260,380 D
2021-08-03 Sale : show line 6 in the form −27,830 $34.00 $946,220 232,550 D
2021-08-03 Exercise or conversion : show line 7 in the form +4,170 $23.98 $99,997 236,720 D
2021-08-03 Sale : show line 8 in the form −4,170 $34.00 $141,780 232,550 D
Open-market sales · 100,000 sh · avg $34.68 · $3,467,764

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2021-08-03 Exercise or conversion : show line 13 in the form Incentive Stock Option (right to buy) −4,170 0 D
2021-08-03 Exercise or conversion : show line 14 in the form Non-Qualified Stock Option (right to buy) −27,830 0 D
2021-08-03 Exercise or conversion : show line 15 in the form Non-Qualified Stock Option (right to buy) −16,225 0 D
2021-08-03 Exercise or conversion : show line 16 in the form Non-Qualified Stock Option (right to buy) −1,775 158,225 D
2021-08-04 Exercise or conversion : show line 17 in the form Non-Qualified Stock Option (right to buy) −38,225 120,000 D
2021-08-04 Exercise or conversion : show line 18 in the form Non-Qualified Stock Option (right to buy) −11,775 108,225 D
Loading xslF345X03/edgardoc.xml…